Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Quest PharmaTechQPTFF Graham Number is $0.13 as of Jan. 2026, which is 30% above its 10-year median of 0.10. Among 251 Biotechnology companies, Quest PharmaTech ranks better than 98.8% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
As of today (2026-08-03), the stock price of Quest PharmaTech is $0.02. Quest PharmaTech's graham number for the quarter that ended in Jan. 2026 was $0.13. Therefore, Quest PharmaTech's Price to Graham Number ratio for today is 0.15.
The historical rank and industry rank for Quest PharmaTech's Graham Number or its related term are showing as below:
QPTFF'
s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.04 Med: 0.1 Max: 0.16
Current: 0.13
During the past 13 years, the highest Price to Graham Number ratio of Quest PharmaTech was 0.16. The lowest was 0.04. And the median was 0.10.
QPTFF's Price-to-Graham-Number is ranked better than 98.8% of 251
companies
in the Biotechnology industry
Industry Median: 1.73
vs QPTFF: 0.13
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
Quest PharmaTech (OTCPK:QPTFF) Graham Number Explanation
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
Quest PharmaTech's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Jan. 2026 )
=
0.02
/
0.13
=
0.15
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
Quest PharmaTech Graham Number Related Terms
Quest PharmaTech Graham Number Historical Data
* Premium members only.
The historical data trend for Quest PharmaTech's Graham Number can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QPTFF vs VRTX, REGN, RVMD: Graham Number Comparison
For the Biotechnology subindustry, Quest PharmaTech's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest PharmaTech Price-to-Graham-Number vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Quest PharmaTech's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where Quest PharmaTech's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quest PharmaTech (QPTFF) has a Graham Number of $0.13 as of Jan. 2026. The Graham Number values a company based on its per-share earnings and book value. View historical data on Quest PharmaTech and its competitors. This is 30% above median its historical median of 0.10. Over the past decade, Quest PharmaTech's Graham Number has ranged from 0.04 to 0.16. According to the industry distribution chart, Quest PharmaTech ranks #3 out of 251 companies in the Biotechnology industry, placing it in the top 1.2%.
Is Quest PharmaTech's Graham Number too high?
Quest PharmaTech's current Graham Number of $0.13 is 30% above median its 10-year median of 0.10. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 0.16. The Biotechnology industry median Graham Number is 1.73. Quest PharmaTech's value of $0.13 is 92.5% below this industry median. Based on the distribution chart, Quest PharmaTech ranks #3 out of 251 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Quest PharmaTech's Graham Number compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Quest PharmaTech ranks #3 out of 251 companies for Graham Number. This places Quest PharmaTech in the top 1% of its industry — outperforming the majority of peers. The industry median Graham Number is 1.73. Quest PharmaTech's value of $0.13 is 92.5% below this benchmark. Historically, Quest PharmaTech's own Graham Number has ranged from 0.04 to 0.16 over the past decade. While the company's 10-year median is 0.10 vs. the industry median of 1.73, Quest PharmaTech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Biotechnology company?
The median Graham Number among Biotechnology companies is 1.73, based on 251 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quest PharmaTech's current Graham Number of $0.13 is 92.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Quest PharmaTech and its competitors. For the Biotechnology industry, the median Graham Number is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quest PharmaTech's current Graham Number is $0.13, which is 30% above median its own 10-year median of 0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest PharmaTech stock overvalued right now?
Quest PharmaTech (QPTFF) has a current Graham Number of $0.13. The current Graham Number is $0.13, which is 30% above median its 10-year median of 0.10 and 92.5% below the Biotechnology industry median of 1.73. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Quest PharmaTech (QPTFF), the current Graham Number is $0.13 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quest PharmaTech Inc is developing targeted cancer therapy with its product (MAb AR9.6), under development for a novel target (truncated O-glycans on MUC16) discovered at the University of Nebraska Medical Center.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
QPTFF has been successfully added to your 
